Peter Laszlo Lakatos (P L Lakatos, Péter L Lakatos, Peter Lakatos, Peter L Lakatos)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 59

Top Venues

Journal of clinical medicine

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

Journal of the Canadian Association of Gastroenterology

McGill University Health Centre

Semmelweis Egyetem (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

McGill University Health Centre Jan 01 2017

Canada

Professor of Medicine, Director of IBD Center :: Department of Medicine

Semmelweis Egyetem Nov 01 1999

Hungary

Head of Gastroenterology, Hepatology and endoscopy :: 1st Department of Medicine

Education History

Semmelweis Egyetem Sep 01 1993 - Sep 01 1999

Hungary

PHD

Publications

Panu Wetwittayakhlang, Talat Bessissow, Peter Laszlo Lakatos
Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials. Expert opinion on emerging drugs (2024)
Livia Lontai, Lívia Priyanka Elek, Fruzsina Balogh, Dorottya Angyal, Péter Pajkossy, Lorant Gonczi, Peter Laszlo Lakatos, Ákos Iliás
Burden of Mental Health among Patients with Inflammatory Bowel Disease-A Cross-Sectional Study from a Tertiary IBD Center in Hungary. Journal of clinical medicine 13 (7) (2024)
Tanawat Pattarapuntakul, Thanawin Wong, Panu Wetwittayakhlang, Nisa Netinatsunton, Suriya Keeratichananont, Apichat Kaewdech, Sawangpong Jandee, Naichaya Chamroonkul, Pimsiri Sripongpun, Peter Laszlo Lakatos
Efficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study. Journal of clinical medicine 13 (12) (2024)
Panu Wetwittayakhlang, Peter Laszlo Lakatos
Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel Diseases. Journal of Crohn's & colitis 18 (5) (2024)
Panu Wetwittayakhlang, Gynter Kotrri, Talat Bessissow, Peter Laszlo Lakatos
How close are we to a success stratification tool for improving biological therapy in ulcerative colitis? Expert opinion on biological therapy 24 (6) (2024)
M Mercédesz Angyal, Mathieu F Janssen, Peter Laszlo Lakatos, Valentin Brodszky, Fanni Rencz
The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease. The European journal of health economics : HEPAC : health economics in prevention and care (2024)
Panu Wetwittayakhlang, Talat Bessissow, Peter Laszlo Lakatos
Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials. Expert opinion on emerging drugs (2024)
Lorant Gonczi, Laszlo Lakatos, Akos Ilias, Peter Laszlo Lakatos
Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras-Authors' reply. Alimentary pharmacology & therapeutics 59 (5) (2024)
Panu Wetwittayakhlang, Peter Laszlo Lakatos
Unravelling the Smoke Trail: Maternal Smoking, Childhood Exposure, and their Impact on Inflammatory Bowel Diseases. Journal of Crohn's & colitis (2024)
Panu Wetwittayakhlang, Gynter Kotrri, Talat Bessissow, Peter Laszlo Lakatos
How close are we to a success stratification tool for improving biological therapy in ulcerative colitis? Expert opinion on biological therapy 24 (6) (2024)
Lorant Gonczi, Laszlo Lakatos, Akos Ilias, Peter Laszlo Lakatos
Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras-Authors' reply. Alimentary pharmacology & therapeutics 59 (5) (2024)
Panu Wetwittayakhlang, Gynter Kotrri, Talat Bessissow, Peter Laszlo Lakatos
How close are we to a success stratification tool for improving biological therapy in ulcerative colitis? Expert opinion on biological therapy (2024)
Panu Wetwittayakhlang, Talat Bessissow, Peter Laszlo Lakatos
Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials. Expert opinion on emerging drugs 29 (1) (2024)
Livia Lontai, Lívia Priyanka Elek, Fruzsina Balogh, Dorottya Angyal, Péter Pajkossy, Lorant Gonczi, Peter Laszlo Lakatos, Ákos Iliás
Burden of Mental Health among Patients with Inflammatory Bowel Disease-A Cross-Sectional Study from a Tertiary IBD Center in Hungary. Journal of clinical medicine 13 (7) (2024)
Tanawat Pattarapuntakul, Thanawin Wong, Panu Wetwittayakhlang, Nisa Netinatsunton, Suriya Keeratichananont, Apichat Kaewdech, Sawangpong Jandee, Naichaya Chamroonkul, Pimsiri Sripongpun, Peter Laszlo Lakatos
Efficacy of Vonoprazan vs. Intravenous Proton Pump Inhibitor in Prevention of Re-Bleeding of High-Risk Peptic Ulcers: A Randomized Controlled Pilot Study. Journal of clinical medicine 13 (12) (2024)
Panu Wetwittayakhlang, Talat Bessissow, Peter Laszlo Lakatos
Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials. Expert opinion on emerging drugs 29 (1) (2024)
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary pharmacology & therapeutics 59 (5) (2023)
Panu Wetwittayakhlang, Peter Laszlo Lakatos
Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology 7 (1) (2023)
Panu Wetwittayakhlang, Lorant Gonczi, Petra A Golovics, Zsuzsanna Kürti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos, Peter Laszlo Lakatos
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of clinical medicine 12 (8) (2023)
Panu Wetwittayakhlang, Lorant Gonczi, Petra A Golovics, Zsuzsanna Kürti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos, Peter Laszlo Lakatos
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of clinical medicine 12 (8) (2023)
M Mercédesz Angyal, Peter Laszlo Lakatos, Balázs Jenei, Valentin Brodszky, Fanni Rencz
Health utilities and willingness to pay in adult patients with coeliac disease in Hungary. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2023)
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Alex Al Khoury, Peter Laszlo Lakatos
Declining trends of reoperations and disease behavior progression in Crohn's disease over different therapeutic eras - a prospective population-based study from western Hungary between 1977-2020, data from the Veszprem cohort. Journal of Crohn's & colitis (2023)
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary pharmacology & therapeutics 59 (5) (2023)
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary pharmacology & therapeutics 59 (5) (2023)
Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Dorottya Angyal, Fruzsina Balogh, Akos Ilias, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary pharmacology & therapeutics (2023)
Panu Wetwittayakhlang, Lorant Gonczi, Petra A Golovics, Zsuzsanna Kürti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos, Peter Laszlo Lakatos
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of clinical medicine 12 (8) (2023)
Panu Wetwittayakhlang, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow, Peter Laszlo Lakatos
The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer. Journal of clinical medicine 12 (6) (2023)
Panu Wetwittayakhlang, Peter Laszlo Lakatos
Current Evidence for Combined Targeted Therapy for the Treatment of Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology 7 (1) (2023)
Panu Wetwittayakhlang, Lorant Gonczi, Petra A Golovics, Zsuzsanna Kürti, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Laszlo Lakatos, Peter Laszlo Lakatos
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of clinical medicine 12 (8) (2023)
Panu Wetwittayakhlang, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow, Peter Laszlo Lakatos
The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer. Journal of clinical medicine 12 (6) (2023)
Panu Wetwittayakhlang, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow, Peter Laszlo Lakatos
The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer. Journal of clinical medicine 12 (6) (2023)
Petra Anna Golovics, Christine Verdon, Panu Wetwittayakhlang, Christopher Filliter, Lorant Gonczi, Gustavo Drügg Hahn, Gary E Wild, Waqqas Afif, Alain Bitton, Talat Bessissow, Paul Brassard, Peter Laszlo Lakatos
Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996-2015. Journal of clinical medicine 11 (3) (2022)
Valerie Heron, Steven Li Fraine, Nicola Panaccione, Sophie Restellini, Pascale Germain, Kristina Candido, Charles N Bernstein, Talat Bessissow, Alain Bitton, Usha K Chauhan, Peter Laszlo Lakatos, John K Marshall, Pierre Michetti, Cynthia H-T Seow, Greg Rosenfeld, Remo Panaccione, Waqqas Afif
Efficacy of Intravenous Ustekinumab Reinduction in Patients With Crohn's Disease With a Loss of Response. Journal of the Canadian Association of Gastroenterology 5 (5) (2022)
Mirabella Zhao, Lóránt Gönczi, Peter Laszlo Lakatos, Burisch J
The Burden of Inflammatory Bowel Disease in Europe in 2020. Journal of Crohn's & colitis 15 (9) (2022)
Zsuzsanna Kurti, Lorant Gonczi, Laszlo Lakatos, Petra Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort. Journal of Crohn's & colitis (2022)
Panu Wetwittayakhlang, Alex Al Khoury, Gustavo Drügg Hahn, Peter Laszlo Lakatos
The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. Journal of clinical medicine 11 (11) (2022)
Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Dirlene Melo Santa Maria, Usiara Britto, Gary Edward Wild, Waqqas Afif, Alain Bitton, Talat Bessissow, Peter Laszlo Lakatos
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Journal of clinical medicine 11 (15) (2022)
Panu Wetwittayakhlang, Lorant Gonczi, Laszlo Lakatos, Zsuzsanna Kurti, Petra Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Long-term Colectomy rates of Ulcerative Colitis over 40-year of Different Therapeutic eras - Results from Western Hungarian Population-based Inception Cohort between 1977-2020. Journal of Crohn's & colitis (2022)
Lorant Gonczi, Laszlo Lakatos, Zsuzsanna Kurti, Petra Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Peter Laszlo Lakatos
Incidence, prevalence, disease course and treatment strategy of Crohn's disease patients from the Veszprem cohort, Western Hungary - a population-based inception cohort study between 2007 and 2018. Journal of Crohn's & colitis (2022)
Gustavo Drügg Hahn, Petra Anna Golovics, Panu Wetwittayakhlang, Alex Al Khoury, Talat Bessissow, Peter Laszlo Lakatos
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing? Biomedicines 10 (4) (2022)
Panu Wetwittayakhlang, Livia Lontai, Lorant Gonczi, Petra A Golovics, Gustavo Drügg Hahn, Talat Bessissow, Peter Laszlo Lakatos
Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology? Journal of clinical medicine 10 (23) (2021)
Laura E Targownik, Charles N Bernstein, Peter Laszlo Lakatos, Sanjay K Murthy, Eric I Benchimol, Alain Bitton, James Guoxian Huang, M Ellen Kuenzig, Jennifer L Jones, Gilaad G Kaplan, Kate Lee, Mariam S Mukhtar, Parul Tandon, Joseph W Windsor, Remo Panaccione
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications. Journal of the Canadian Association of Gastroenterology 4 (Suppl 2) (2021)
Gilaad G Kaplan, Joseph W Windsor, Janet Crain, Lisa Barrett, Charles N Bernstein, Alain Bitton, Usha K Chauhan, Stephanie Coward, Sharyle Fowler, Jean-Eric Ghia, Deanna L Gibson, Anne M Griffiths, Jennifer L Jones, Reena Khanna, M Ellen Kuenzig, Peter Laszlo Lakatos, Kate Lee, David R Mack, John K Marshall, Mina Mawani, Sanjay K Murthy, Remo Panaccione, Cynthia H-T Seow, Laura E Targownik, Sandra Zelinsky, Eric I Benchimol
Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy. Journal of the Canadian Association of Gastroenterology 4 (Suppl 2) (2021)
Timothy Raine, Stefanos Bonovas, Burisch J, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Rose Hedin, Stefan D Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Laszlo Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin M Noor, Gianluca Pellino, Daniele Piovani, Edoardo Vincenzo Savarino, Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panis, Glen Doherty
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Journal of Crohn's & colitis (2021)
Panu Wetwittayakhlang, Farah Albader, Petra A Golovics, Gustavo Drügg Hahn, Talat Bessissow, Alain Bitton, Waqqas Afif, Gary Wild, Peter Laszlo Lakatos
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Canadian journal of gastroenterology & hepatology 2021 (2021)
M Ellen Kuenzig, Joseph W Windsor, Lisa Barrett, Charles N Bernstein, Alain Bitton, Matthew W Carroll, Usha K Chauhan, Stephanie Coward, Sharyle Fowler, Jean-Eric Ghia, Rose Geist, Deanna L Gibson, Lesley A Graff, Anne M Griffiths, James Guoxian Huang, Jennifer L Jones, Reena Khanna, Peter Laszlo Lakatos, Kate Lee, David R Mack, John K Marshall, Mariam S Mukhtar, Sanjay K Murthy, Geoffrey C Nguyen, Remo Panaccione, Cynthia H-T Seow, Harminder Singh, Parul Tandon, Laura E Targownik, Sandra Zelinsky, Eric I Benchimol, Gilaad G Kaplan
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary. Journal of the Canadian Association of Gastroenterology 4 (Suppl 2) (2021)
Petra Anna Golovics, Lorant Gonczi, Jason Reinglas, Christine Verdon, Sheetal Pundir, Waqqas Afif, Gary Wild, Alain Bitton, Talat Bessissow, Peter Laszlo Lakatos
Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study. Digestive diseases and sciences (2021)
Antonino Spinelli, Stefanos Bonovas, Burisch J, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Rose Hedin, Stefan D Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Laszlo Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin M Noor, Gianluca Pellino, Daniele Piovani, Edoardo Vincenzo Savarino, Francesco Selvaggi, Bram Verstockt, Glen Doherty, Timothy Raine, Yves Panis
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. Journal of Crohn's & colitis (2021)
Panu Wetwittayakhlang, Petra A Golovics, Waqqas Afif, Talat Bessissow, Peter Laszlo Lakatos
Tofacitinib-Associated Iatrogenic Kaposi Sarcoma in a Patient With Ulcerative Colitis. ACG case reports journal 8 (11) (2021)
Panu Wetwittayakhlang, Peter Laszlo Lakatos
Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters! Journal of Crohn's & colitis 15 (11) (2021)
S Restellini, Peter Laszlo Lakatos
Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle. Journal of Crohn's & colitis 15 (7) (2021)
Alex Al Khoury, Bhairavi Balram, Talat Bessissow, Waqqas Afif, Lorant Gonczi, Maria Abreu, Peter Laszlo Lakatos
Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive diseases and sciences (2021)
Joao Goncalves, Fernando Magro, Silvio Danese, Peter Laszlo Lakatos, Shomron Ben-Horin
Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply. Alimentary pharmacology & therapeutics 48 (5) (2019)
Christine Verdon, Talat Bessissow, Peter Laszlo Lakatos
Management of Acute Severe Colitis in the Era of Biologicals and Small Molecules. Journal of clinical medicine 8 (12) (2019)
Jason Reinglas, Lorant Gonczi, Christine Verdon, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest Seidman, Alain Bitton, Peter Laszlo Lakatos
Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center. Digestive diseases and sciences 65 (7) (2019)
Fanni Rencz, Peep F M Stalmeier, Márta Péntek, Valentin Brodszky, Gabor Ruzsa, Lóránt Gönczi, Károly Palatka, László Herszényi, Eszter Schäfer, János Banai, Mariann Rutka, László Gulácsi, Peter Laszlo Lakatos
Patient and general population values for luminal and perianal fistulising Crohn's disease health states. The European journal of health economics : HEPAC : health economics in prevention and care 20 (Suppl 1) (2019)
Joao Goncalves, M Santos, R Acurcio, I Iria, L Gouveia, P Matos Brito, A Catarina Cunha-Santos, A Barbas, J Galvão, I Barbosa, F Aires da Silva, A Alcobia, M Cavaco, M Cardoso, J Delgado Alves, J J Carey, T Dörner, J Eurico Fonseca, C Palmela, J Torres, C Lima Vieira, D Trabuco, G Fiorino, Anne S Strik, M Yavzori, I Rosa, L Correia, Fernando Magro, G D'Haens, S Ben-Horin, Peter Laszlo Lakatos, S Danese
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition. Alimentary pharmacology & therapeutics 48 (5) (2018)
Fanni Rencz, Peter Laszlo Lakatos, László Gulácsi, Valentin Brodszky, Zsuzsanna Kürti, Szilvia Lovas, János Banai, László Herszényi, Tamás Cserni, Tamás Molnár, Márta Péntek, Károly Palatka
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 28 (1) (2018)
Z Vegh, T Bessissow, W Afif, Peter Laszlo Lakatos
Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Alimentary pharmacology & therapeutics 45 (8) (2017)

Peter Laszlo Lakatos.css-eqlu8i{font-size:small;padding-left:4px;} (P L Lakatos, Péter L Lakatos, Peter Lakatos, Peter L Lakatos)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Laszlo Lakatos (P L Lakatos, Péter L Lakatos, Peter Lakatos, Peter L Lakatos)